EAM
SGNT

Eagle Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Eagle Asset Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,057,873
Closed -$15.8M – 681
2016
Q2 		$15.8M Buy
1,057,873
+14,846
+1% +$191K 0.11% 254
2016
Q1 		$12.7M Buy
1,043,027
+36,844
+4% +$517K 0.09% 299
2015
Q4 		$16M Buy
1,006,183
+639,254
+174% +$10.1M 0.11% 258
2015
Q3 		$5.63M Buy
+366,929
New +$7.93M 0.04% 396

Eagle Asset Management's SGNT Position: Q3 2016 in Review

Eagle Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 1,057,873 shares — an estimated $15.8M sold.

Eagle Asset Management first reported a position in SGNT in Q3 2015 and held it in 4 quarters. The position peaked at $16M in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Eagle Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Eagle Asset Management sold 1,057,873 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $15.8M.
  • Eagle Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2015 and held it in 4 quarters.
  • Eagle Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $16M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Eagle Asset Management's 13F filing for Q3 2016, filed 12 Oct 2016.